Clinuvel Pharmaceuticals
CUV.AX
#6929
Rank
S$0.57 B
Marketcap
$11.54
Share price
-1.79%
Change (1 day)
-20.87%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2023: S$40.59 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are S$51.84 Million. In 2023 the company made an earning of S$40.59 Million, an increase over its 2022 earnings that were of S$31.76 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2023

Annual earnings

Year Earnings Change
2023S$40.59 M27.77%
2022S$31.76 M22.23%
2021S$25.99 M114.01%
2020S$12.14 M-29.03%
2019S$17.11 M32.76%
2018S$12.88 M75.24%
2017S$7.35 M-332.09%
2016-S$3.17 Million-70.52%
2015-S$10.76 Million53.56%
2014-S$7.01 Million-16.31%
2013-S$8.37 Million-37.85%
2012-S$13.46 Million-18%
2011-S$16.42 Million25.86%
2010-S$13.05 Million-21.79%
2009-S$16.68 Million-11.73%
2008-S$18.89 Million80.71%
2007-S$10.46 Million-2.86%
2006-S$10.77 Million-4.95%
2005-S$11.33 Million60.55%
2004-S$7.06 Million97.37%
2003-S$3.58 Million50.62%
2002-S$2.38 Million121.22%
2001-S$1.08 Million254.48%
2000-S$0.31 Million